Chase AIPricingFAQs
Display currency
Loading news…

Evolus

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Irvine, California, United States Founded 2012 251-500 employees For Profit

Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
268
Ticker
EOLS
NASDAQ

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
EOLS
Exchange
NASDAQ
IPO date
Feb 8, 2018
Raised at IPO
$60M
Valuation at IPO
$283M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
82
Mobile apps
1
Active products
43
IT spend
$6.44M

Company Info

Founded
2012
Employees
251-500
Operating status
Active
Company type
For Profit
Org types
company
News articles
243
HQ
Irvine, California, United States
Region
Greater Los Angeles Area, West Coast, Western US
Exit date
Feb 8, 2018

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
1.5
Trend (30d)
3.6
Trend (90d)
5.9
Last leadership hire
Sep 8, 2025
268
professional contacts at Evolus
Contact execs at Evolus

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Evolus

Loading news…

FAQs about Evolus

People who checked this page also checked these

Browse the full Acquirezy directory.
Evolus - Company Profile, Full Acquisitions List, Funding and Investments